Market Overview

15 Biggest Mid-Day Losers For Friday

  • T2 Biosystems Inc (NASDAQ: TTOO) shares tumbled 22.1 percent to $4.74. T2 Biosystems priced its 4.375 million share offering at $4 per share.
  • Ominto Inc (NASDAQ: OMNT) shares dropped 19.2 percent to $2.77.
  • LM Funding America, Inc. (NASDAQ: LMFA) shares fell 13.3 percent to $ 2.57.
  • BioTelemetry, Inc. (NASDAQ: BEAT) shares declined 9.5 percent to $33.60.
  • 22nd Century Group Inc (NYSE: XXII) shares fell 8 percent to $2.78.
  • Adomani Inc (NASDAQ: ADOM) shares declined 8 percent to $7.37.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) shares dropped 7.6 percent to $2.20.
  • Opiant Pharmaceuticals Inc (NASDAQ: OPNT) shares fell 6.7 percent to $25.00 after dropping 27.56 percent on Thursday. Opiant Pharmaceuticals issued an update on NARCAN® Nasal Spray.
  • Oracle Corporation (NYSE: ORCL) shares dropped 6.4 percent to $49.42. Oracle reported better-than-expected results for its first quarter, but issued a weak profit forecast for the current quarter.
  • First Internet Bancorp (NASDAQ: INBK) declined 6.3 percent to $29.10. First Internet Bancorp priced 1.65 million shares at $29 per share.
  • Tyme Technologies Inc (NASDAQ: TYME) shares fell 6.3 percent to $6.47.
  • Immune Design Corp (NASDAQ: IMDZ) declined 5 percent to $8.85. RBC Capital initiated coverage of Immune Design with an Outperform rating and $20 price target.
  • Acuity Brands, Inc. (NYSE: AYI) fell 4.8 percent to $169.50. Wells Fargo downgraded Acuity Brands from Outperform to Market Perform.
  • Carnival Corporation (NYSE: CCL) shares dropped 4.7 percent to $65.53. Credit Suisse downgraded Carnival from Outperform to Neutral.
  • Altice USA Inc (NYSE: ATUS) slipped 3.6 percent to $28.44. Guggenheim downgraded Altice USA from Buy to Neutral.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings Movers


Related Articles (AEMD + ADOM)

View Comments and Join the Discussion!

Latest Ratings

NICEJP MorganUpgrades150.0
MRVLBank of AmericaReiterates28.0
LFUSLongbow ResearchDowngrades0.0
ONLongbow ResearchDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Oracle's Q1: Things To Like A Lot, Things To Like Less

Montel Williams' Battle With Multiple Sclerosis And The Miracle Of Medical Marijuana